CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis-Reference-Cited by-同舟云学术

CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis

Published:2016-05 Issue:3 Volume:9 Page:689-701
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Brasseit J,Althaus-Steiner E,Faderl M,Dickgreber N,Saurer L,Genitsch V,Dolowschiak T,Li H,Finke D,Hardt W-D,McCoy K D,Macpherson A J,Corazza N,Noti M,Mueller C

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi201593.pdf

Reference48 articles.

1. Khanna, P.V., Shih, D.Q., Haritunians, T., McGovern, D.P. & Targan, S. Use of animal models in elucidating disease pathogenesis in IBD. Semin. Immunopathol. 36, 541–551 (2014).

2. D'Haens, G.R., Sartor, R.B., Silverberg, M.S., Petersson, J. & Rutgeerts, P. Future directions in inflammatory bowel disease management. J. Crohns Colitis 8, 726–734 (2014).

3. Merga, Y., Campbell, B.J. & Rhodes, J.M. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Dig. Dis. 32, 475–483 (2014).

4. Johansson, M.E.V. et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281–291 (2013).

5. Johansson, M.E.V. et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 5, e12238 (2010).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade;Molecular Therapy: Oncology;2024-09

2. Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease;Molecular Diagnosis & Therapy;2024-04-18

3. CD40 is an immune checkpoint regulator that potentiates myocardial inflammation through activation and expansion of CCR2⁺macrophages and CD8 T-cells;2024-03-16

4. The Function of Necroptosis and Its Treatment Target in IBD;Mediators of Inflammation;2024-01

5. Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses;Molecular Therapy;2023-05